Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Ginkgo Extract Has Multiple Actions on Alzheimer Symptoms

26.08.2008
Maryland School of Pharmacy researchers are learning how Ginkgo biloba extract works on memory symptoms.

Scientists have known for more than 10 years that a certain extract from leaves of the ancient eastern tree, Ginkgo biloba, can somewhat ease symptoms of memory loss in Alzheimer’s disease patients.

Now, researchers at the University of Maryland School of Pharmacy are learning how the popular extract actually works in Alzheimer’s patients.

Understanding the biochemical workings of the ginkgo extract could help doctors expand treatment options for other medical conditions. A synergy, or the combination of separate actions by the Ginkgo extract, common in herbal remedies, may be the key to its effectiveness, says Yuan Luo, PhD, associate professor at the School of Pharmacy.

In ongoing studies, a research team led by Luo found that giving mice with the human Alzheimer’s gene the ginkgo extract called Egb 761 improved the process of making new nerve cells in part of the brain much affected by the disease. The team found evidence that the protective effect of the extract also could be due to decreasing senile plaques or the clumping of beta-amyloid in the brain tissues. Amyloid is part of a protein and a central factor in the progression of Alzheimer’s disease.

Currently Alzheimer’s disease is causing progressive dementia and sometimes death in about four million Americans, mostly people older than 70. In the U.S., the incidence of Alzheimer’s disease has steadily increased as the average life span has lengthened. Currently, there are no drugs with disease-modifying or preventive properties. However, the School of Pharmacy study and others are now suggesting that many of the symptoms can be avoided or significantly reduced.

The disease starts with loss of nerve connections and broken circuitry of nerve signals in synapses. Modern neuropathology studies beginning in the 1960’s revealed that adults create new nerve cells continually in learning regions of the brain. One of the regions of neurogenesis is in the hippocampus, important to memory and cognition. Luo’s study demonstrated the dual effect of Ginkgo extract in the hippocampus—enhanced making of nerve cells and decreased clumping in brain tissue.

“By finding out how it works, it might help drug discovery researchers and doctors learn how other herbal and conventional drugs work on in multiple ways,” said Luo. When herbal medicines are effective, she said, it’s often because of a synergy of different biological effects. “Alzheimer’s disease is caused by multiple factors, not just one thing that has gone wrong.” Therefore, drugs that target multiple sites would be most efficacious, she added.

Results from the School of Pharmacy experiments, slated to continue for at least another year, provide a rationale for future medicinal chemistry and for identifying other potentially efficacious compounds with desirable activity as potential therapeutic agents to prevent and/or treat Alzheimer’s disease, according to Luo.

Meanwhile, to confirm or refute the theory that medicine made from Ginkgo biloba can prevent or delay changes in memory, thinking, and personality as people get older, researchers are currently analyzing data from a five-year clinical trial, The Ginkgo Evaluation of Memory, sponsored by the National Institutes of Health. About 3,000 people at four clinics, including one in Hagerstown, Md., participated.

Luo’s research team is focused on aging, age-related neurodegenerative diseases, and neuroprotective mechanisms. While disease prevention theories associated with herbal medicine have the potential to both increase quality of life and reduce health care costs, ways that extracts of herbs work in the body are still poorly understood, she says.

Steve Berberich | Newswise Science News
Further information:
http://www.umaryland.edu

More articles from Life Sciences:

nachricht Toward a 'smart' patch that automatically delivers insulin when needed
18.01.2017 | American Chemical Society

nachricht 127 at one blow...
18.01.2017 | Stiftung Zoologisches Forschungsmuseum Alexander Koenig, Leibniz-Institut für Biodiversität der Tiere

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

A big nano boost for solar cells

18.01.2017 | Power and Electrical Engineering

Glass's off-kilter harmonies

18.01.2017 | Materials Sciences

Toward a 'smart' patch that automatically delivers insulin when needed

18.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>